The main function of PPAR is to regulate the transcription of genes.
PPAR的主要功能是调节基因的转录。
If you're obese, there's a good chance your PPAR system is idling too low.
如果你是肥胖者，很有可能PPAR系统太闲了。
The establishment of yeast-based screen platform for PPAR agonists and antagonists.
基于酵母水平PPAR 激动剂和抑制剂筛选模型的建立；
Rosiglitazone belongs to a class of drugs known as peroxisome proliferator-actiated receptor (PPAR) agonists.
罗格列酮属于称为过氧化物酶体活化受体（PPAR）促效剂一类药物。
Even more worrisome, this has called into question the use of all thiazolidinediones and all PPAR-directed agents.
更令人烦恼的是，这已经引发了所有噻唑烷二酮类药物和所有PPAR方面药物的使用问题。
However, by administering PPAR, they were able to bypass the defects in insulin signaling and preserve the cells that need insulin to thrive.
通过应用PPAR，他们能够绕过损伤的胰岛素信号通路，使得需要胰岛素的细胞得以存活。
The major effects of the PPAR treatments were to increase brain size, preserve insulin and IGF-II receptor bearing neurons, and preserve learning and memory.
PPAR治疗的主要效应是增加大脑的体积，保存胰岛素和IGF - II受体突起神经元，保持学习和记忆。
So, Spiegelman and colleagues undertook studies to determine whether PPAR agonists might be useful as adjuvant therapy with currently used chemotherapeutics.
因此，Spiegelman和他的同事着手研究以确定PPAR激动剂是否可以作为目前化疗的有用的辅助治疗。
These studies demonstrated improved blood sugar control when Januvia was used alone or in patients not satisfactorily managed with metformin or a PPAR agonist.
这些研究证明改善血糖控制在Januvia单方使用效果不满意的可与二甲双胍或PPAR增效剂复方使用。
Agonists of PPAR, a member of the nuclear hormone receptor family of transcription factors, are widely used in the treatment of type II diabetes and are relatively non-toxic.
PPAR激动剂，是细胞核激素受体家族转录因子的一个成员，被广泛用来治疗II型糖尿病，而且相对无毒。
Chemotherapy given in combination with ligands for the peroxisome proliferator-activated receptor - (PPAR) synergistically inhibits the growth of lung and ovarian cancer cell lines.
化疗药物联合过氧化物酶体增殖物激活受体(PPAR)的配体能够协同抑制肺细胞癌及卵巢癌细胞。
Chemotherapy given in combination with ligands for the peroxisome proliferator-activated receptor - (PPAR) synergistically inhibits the growth of lung and ovarian cancer cell lines.
化疗药物联合过氧化物酶体增殖物激活受体(PPAR)的配体能够协同抑制肺细胞癌及卵巢癌细胞。
应用推荐